SCHEMBL580176

SCHEMBL580176

NN1C=NC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL4983314 0.87
SCHEMBL6427950 0.67
SCHEMBL8508693 0.67
SCHEMBL580953 0.67
SCHEMBL1431147 0.67
SCHEMBL17157487 0.67
SCHEMBL3170280 0.64
Hydrochloric Acid SCHEMBL933129 0.62
Hydrochloric Acid SCHEMBL17730390 0.62
SCHEMBL2146911 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119657051-A Temperature control method and reaction device of thermotropic liquid crystal polyester synthesis reaction kettle 浙江聚领新材料有限公司 2025-03-21 CN claimed
CN-119607910-A Modified two-dimensional metal organic framework nano sheet membrane and preparation method and separation application thereof 中国科学院大连化学物理研究所 2025-03-14 CN claimed
CN-115010924-A Photosensitive polyimide resin composition, polyimide resin film containing same and application of polyimide resin film 吉林奥来德光电材料股份有限公司 2022-09-06 CN claimed
CN-109608464-A A kind of radioiodination Larotrectinib compound and its preparation method and application 上海健康医学院 2019-04-12 CN claimed
US-20260022100-A1 NAV1.8 INHIBITOR Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2026-01-22 US disclosed
WO-2025242880-A1 THERAPEUTIC COMPOUNDS AND THEIR USE MY-T BIO LIMITED (GB) 2025-11-27 WO disclosed
EP-4545517-A1 NAV1.8 INHIBITOR Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2025-04-30 EP disclosed
CN-119657051-A Temperature control method and reaction device of thermotropic liquid crystal polyester synthesis reaction kettle 浙江聚领新材料有限公司 2025-03-21 CN disclosed
CN-119607910-A Modified two-dimensional metal organic framework nano sheet membrane and preparation method and separation application thereof 中国科学院大连化学物理研究所 2025-03-14 CN disclosed
US-12233064-B1 Antarctic tunicate Synoicum species-derived alkaloids and methods of treatment UNIVERSITY OF SOUTH FLORIDA (US) 2025-02-25 US disclosed
CN-115916777-B ATX inhibitor and preparation method and application thereof 苏州爱科百发生物医药技术有限公司 2024-07-12 CN disclosed
WO-2023246867-A1 NAV1.8 INHIBITOR 武汉人福创新药物研发中心有限公司 2023-12-28 WO disclosed
US-20060009453-A1 Protein kinase modulators and method of use AMGEN INC. 2006-01-12 US disclosed
WO-2005113494-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2005-12-01 WO disclosed
US-20050245512-A1 Method and composition for rejuvinating cells, tissues organs, hair and nails ULRICH PETER C 2005-11-03 US disclosed
US-6777557-B2 Method and composition for rejuvenating cells, tissues organs, hair and nails FARRINGTON PHARMACEUTICALS, LLC 2004-08-17 US disclosed
EP-1368029-A2 METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS Farrington Pharmaceuticals, LLC (US) 2003-12-10 EP disclosed
CN-1398266-A N-(5,7-dimethoxy[1,2,4] triazolo[1,5-a]pyrimidin-2-yl) arylsulfonamide compounds and their use as herbicides DOW AGROSCIENCES LLC (US) 2003-02-19 CN disclosed
US-20020188015-A1 Method and composition for rejuvinating cells, tissues organs, hair and nails FARRINGTON PHARMACEUTICALS, LLC 2002-12-12 US disclosed
WO-2002062301-A2 METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS FARRINGTON PHARMACEUTICALS, LLC (US) 2002-08-15 WO disclosed